Oseltamivir Phosphate Capsule — FDA Drug Shortage

To Be Discontinued — Genentech, Inc

The FDA lists a drug shortage record for Oseltamivir Phosphate Capsule (capsule) from Genentech, Inc with status To Be Discontinued. The shortage was first posted on 09/30/2025.

Shortage Details

Status
To Be Discontinued
Company
Genentech, Inc
Package NDC
0004-0801-85
Dosage Form
Capsule
Presentation
Tamiflu, Capsule, 45 mg (NDC 0004-0801-85)
Initial Posting
09/30/2025
Revised Date